Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast
WALNUT
1 other identifier
interventional
21
1 country
1
Brief Summary
Prospective, randomized, subject-masked 3-arm clinical study to assess the pediatric acceptability across three iterations of a novel spectacle lens design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 19, 2018
CompletedFirst Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
December 3, 2018
CompletedDecember 3, 2018
November 1, 2018
3 months
November 29, 2018
November 30, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
Distance Visual Acuity
Measurement of best corrected distance visual acuity
2 weeks
Contrast Sensitivity
Measurement of contrast sensitivity
2 weeks
Subjective Responses
Assessment of subject responses related to wear time of spectacles
2 weeks
Study Arms (3)
Lens Design 1
EXPERIMENTALSpectacle lenses design 1, fitted into spectacle frames
Lens Design 2
EXPERIMENTALSpectacle lenses design 2, fitted into spectacle frames
Lens Design 3
EXPERIMENTALSpectacle lenses design 3, fitted into spectacle frames
Interventions
Spectacle lenses with clear central apertures
Eligibility Criteria
You may qualify if:
- Ages between 6 and 12 years
- Myopia between -1.00 and -4.00 D
You may not qualify if:
- Participating in any clinical or other research study
- Contact lens wearer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Ocular Research & Education
Waterloo, Ontario, N2L 3G1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Joe Rappon, OD, MS
SightGlass Vision
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2018
First Posted
December 3, 2018
Study Start
May 1, 2018
Primary Completion
July 19, 2018
Study Completion
July 19, 2018
Last Updated
December 3, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share